Financial Performance - Net sales for Q1 2025 were $814.3 million, a 1.0% increase from $800.5 million in Q1 2024[15] - Gross profit for Q1 2025 was $368.9 million, up from $357.4 million in Q1 2024, reflecting a gross margin improvement[15] - Operating income decreased to $142.0 million in Q1 2025 from $161.2 million in Q1 2024, a decline of 11.1%[15] - Net income attributable to IDEX for Q1 2025 was $95.5 million, down 21.4% from $121.4 million in Q1 2024[15] - Basic earnings per share for Q1 2025 were $1.26, compared to $1.60 in Q1 2024, a decrease of 21.3%[15] - The company reported a comprehensive income of $149.2 million for Q1 2025, significantly higher than $57.0 million in Q1 2024[16] - The Adjusted EBITDA for the total segments was $236.9 million for the three months ended March 31, 2025, slightly down from $238.2 million in the same period of 2024[39] - Diluted EPS for Q1 2025 was $1.26, down 21% from $1.60 in Q1 2024, while adjusted diluted EPS decreased by 7% to $1.75[95][96] - Reported net income for Q1 2025 was $95.4 million, down from $121.3 million in Q1 2024, representing a decrease of 21.5%[140] - Net income margin decreased to 11.7% in Q1 2025 from 15.2% in Q1 2024[140] - Adjusted EBITDA margin also saw a decline to 25.5% in Q1 2025 from 26.0% in Q1 2024[140] Assets and Liabilities - Total assets increased to $6,795.1 million as of March 31, 2025, compared to $6,745.3 million at December 31, 2024[19] - Cash and cash equivalents decreased to $594.1 million from $620.8 million at the end of 2024[19] - Total borrowings as of March 31, 2025, amounted to $1,950.4 million, a decrease from $1,971.3 million as of December 31, 2024[55] - The fair value of total borrowings as of March 31, 2025, was $1,846.5 million, compared to a carrying amount of $1,949.2 million[62] - The company had $249.0 million outstanding under its Revolving Facility, with a net available borrowing capacity of approximately $548.0 million[55] Segment Performance - The Fluid & Metering Technologies segment generated net sales of $290.5 million in Q1 2025, down from $313.7 million in Q1 2024, reflecting a decrease of 7.1%[37] - The Health & Science Technologies segment reported net sales of $341.5 million in Q1 2025, an increase from $310.1 million in Q1 2024, marking a growth of 10.5%[37] - The Fire & Safety/Diversified Products segment achieved a 4% increase in net sales to $184.3 million, driven by targeted growth initiatives[111][113] Cash Flow and Investments - Net cash flows provided by operating activities for Q1 2025 were $105.7 million, down from $156.6 million in Q1 2024[23] - Cash flows from operating activities decreased by $50.9 million to $105.7 million for the three months ended March 31, 2025, mainly due to increased investments in working capital[120] - Free cash flow for the three months ended March 31, 2025, was $91.4 million, down from $136.6 million in the prior year[124] Shareholder Returns - Total dividend payments to common shareholders increased to $52.4 million in Q1 2025, compared to $48.5 million in Q1 2024[128] - The company repurchased 0.3 million shares at a cost of $50.0 million during the three months ended March 31, 2025[127] - The company repurchased 0.3 million shares at a cost of $50.4 million during Q1 2025, leaving $489.7 million remaining in share repurchase authorization[72] Expenses and Costs - Selling, general and administrative expenses increased by 7% to $209.4 million, primarily due to acquisition-related costs[97][100] - Restructuring expenses surged to $17.5 million, compared to $1.1 million in the same period last year, reflecting higher severance costs[97][101] - Acquisition-related costs incurred during the three months ended March 31, 2025, were $0.7 million, compared to $1.3 million in the same period of 2024[34] Tax and Legal Matters - The effective tax rate for the three months ended March 31, 2025, was 23.4%, compared to 21.5% for the same period in 2024[89] - The company is involved in ongoing legal proceedings related to asbestos claims, but does not expect these to have a material adverse effect on its financial position[148] Market and Economic Conditions - The company expects to mitigate potential unfavorable impacts from tariffs and global trade policy changes through price increases and cost reductions[94] - Organic sales for the three months ended March 31, 2025, decreased by 1% compared to the prior year, primarily due to lower volumes in the semiconductor, automotive, and industrial sectors[115] Miscellaneous - The company maintained an interest coverage ratio of 14.08 to 1 and a leverage ratio of 2.22 to 1 as of March 31, 2025, in compliance with financial covenants[129] - There were no material changes in market risks or risk factors compared to the previous fiscal year[141][149] - The company's disclosure controls and procedures were deemed effective as of March 31, 2025[143]

I have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoughts with the Seeking Alpha community. Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...

IDEX Corporation’s (IEX) first-quarter 2025 adjusted earnings of $1.75 per share surpassed the Zacks Consensus Estimate of $1.64. The bottom line decreased 7% from the year-ago quarter’s earnings of $1.88 per share. Management projected adjusted earnings to be in the band of $1.18-$1.24 per share in the quarter.(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)IEX’s Revenue DetailsIDEX’s net sales of $814.3 million beat the Zacks Consensus Estimate of $811 million. The top line increa ...

First Quarter 2025 Earnings May 1, 2025 Click Here to Edit Title Cautionary Statement Click Here to Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's second quarter 2025 and full year 2025 outlook including expected sales, expected organic sales, exp ...

Idex (IEX) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.71%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $2.03 per share when it actually produced earnings of $2.04, delivering a surprise of 0.49%. ...

IDEX (IEX) Q1 2025 Earnings Call May 01, 2025 09:00 AM ET Speaker0 Please note this conference is being recorded. I will now turn the conference over to your host, Jim Gianacoros. Thank you. You may begin. Speaker1 Thank you. Good morning, everyone, and welcome to IDEXX's first quarter twenty twenty five earnings conference call. We released our first quarter financial results earlier this morning, and you can find both our press release and earnings call slide presentation in the Investor Relations section ...

(All comparisons are against the prior year period unless otherwise noted) NORTHBROOK, IL, May 1, 2025 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2025. "Our IDEX teams delivered better than expected revenue and profitability in the first quarter of 2025, with all segments exceeding our expectations. Most encouragingly, all of our segments built backlog, mostly accumulating within HST, fueled by an impressive large clean water project win f ...

IDEX Corporation (IEX) shares rallied 7.3% in the last trading session to close at $173.80. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.4% loss over the past four weeks.IDEX’s rally is largely driven by optimism over its strong momentum in the intelligent water business. The Trump administration’s announcement of a temporary halt on reciprocal tariffs for most countries has also supported the stock’s u ...

IDEX Corporation (IEX) is benefiting from solid momentum in the Fluid & Metering Technologies segment. Persistent strength in the intelligent water business, driven by solid demand in the North American municipal market, bodes well for the segment. The segment’s organic revenues increased 3% on a year-over-year basis in the fourth quarter of 2024. Driven by the favorable trend in its business, the company anticipates overall organic revenues to increase 1-3% year over year in 2025.The company intends to str ...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 - Reference is made to the stock exchange announcements from IDEX Biometrics ASA (the "Compan ...